Chenglong Xie

2.2k citations
38 papers · 701 indexed · h-index 14
Topics
Parkinson's Disease Mechanisms and Treatments (16 papers)Neurological disorders and treatments (10 papers)Alzheimer's disease research and treatments (6 papers)

In The Last Decade

Chenglong Xie

36 papers receiving 692 citations

Peers

Chenglong Xie
Comparison fields: 5 of 93
  • Molecular Biology 264
  • Neurology 201
  • Physiology 164
  • Cellular and Molecular Neuroscience 135
  • Epidemiology 119
Replace Zhipeng Teng with:
Zhipeng Teng China
Sonia Luz Albarracín Colombia
Geneviève Bureau Canada
Huanying Shi China
Yuxia Xu China
Siyan Chen China
Zulma Casas Colombia
Esmael Izadpanah Iran
Amarjot Kaur Grewal India
Chenglong Xie relative to Zhipeng Teng China Zhipeng Teng's profile →
Citations per field
00.5×2.6×
Zhipeng Teng · 1×
Citations per year

Countries citing papers authored by Chenglong Xie

Since Specialization
Citations

This map shows the geographic impact of Chenglong Xie's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chenglong Xie with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chenglong Xie more than expected).

Fields of papers citing papers by Chenglong Xie

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chenglong Xie. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chenglong Xie. The network helps show where Chenglong Xie may publish in the future.

Co-authorship network of co-authors of Chenglong Xie

This figure shows the co-authorship network connecting the top 25 collaborators of Chenglong Xie. A scholar is included among the top collaborators of Chenglong Xie based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chenglong Xie. Chenglong Xie is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 1
2 0
3 0
4 2
5 9
6 1
7 3
8 36
9 15
10 39
11 27
12 16
13 54
14 8
15 13
16 85
17 69
18 10
19 26
20 30

About Chenglong Xie

Chenglong Xie is a scholar working on Neurology, Geriatrics and Gerontology and Cellular and Molecular Neuroscience, having authored 38 papers that have together received 701 indexed citations. Recurring topics across this work include Parkinson's Disease Mechanisms and Treatments (16 papers), Neurological disorders and treatments (10 papers) and Alzheimer's disease research and treatments (6 papers). The work is most often cited by research in Neurology (201 citations), Molecular Medicine (57 citations) and Biological Psychiatry (24 citations). Chenglong Xie has collaborated with scholars based in China, Norway and United Kingdom. Frequent co-authors include Wenwen Wang, Xinshi Wang, Zengrui Zhang, Ruiyu Han, Siyan Chen, Yingying Gu, Xingru Zhang, Manman Zhang, Wenwen Wang and Jia Li. Their work appears in journals such as Advanced Functional Materials, Scientific Reports and Journal of Ethnopharmacology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026